Table 1.
Characteristic* | Study Sample (N=354) |
---|---|
Patient Characteristics | |
Age, mean (SD), years | 64.6 (11.5) |
Male sex | 232 (66) |
Race | |
White | 291 (82) |
Black | 16 (5) |
Other | 47 (13) |
Hypertension | 293 (83) |
Hyperlipidemia | 53 (15) |
Diabetes mellitus | 66 (19) |
Atrial fibrillation | 28 (8) |
Warfarin use | 21 (6) |
Antiplatelet use | 68 (19) |
Admission Laboratory Data | |
Platelet count†, ×103 per microliter | 217 (182–259) |
International Normalized Ratio† | 1.0 (0.9–1.1) |
aPTT†, seconds | 24.6 (21.5–29.2) |
AST†, units/liter | 23 (2–38) |
ALT†, units/liter | 20 (15–29) |
Albumin†, gram/dL | 41 (39–44) |
Total bilirubin†, milligram/dL | 0.5 (0.3–0.7) |
Admission Intracerebral Hemorrhage Data | |
Glasgow Coma Scale† | 15 (14–15) |
National Institutes of Health Stroke Scale† | 13 (9–17) |
Intraventricular hemorrhage | 107 (30) |
Hematoma location | |
Lobar | 73 (21) |
Deep | 274 (77) |
Infratentorial | 7 (2) |
Time to admission CT scan†, hours | 1.8 (1.1–2.5) |
Hematoma volume at admission†, mL | 14.8 (7.5–26.3) |
Perihematoma edema volume at admission†, mL | 8.6 (4.7–14.3) |
96-hour Intracerebral Hemorrhage Imaging Data | |
Time to 96-hour CT scan†, hours | 87.6 (83.2–98.2) |
Hematoma volume at 96 hours†, mL | 17.1 (8.2–33.9) |
Perihematoma edema volume at 96 hours†, mL | 23.3 (11.7–37.2) |
Abbreviations; VISTA-ICH, Virtual International Stroke Trials Archive-Intracerebral Hemorrhage; SD, standard deviation; aPPT, activated partial thromboplastin time; AST, aspartate aminotransferase; ALT, alanine aminotransferase; dl, deciliter; mL, milliliters; μL, microliter.
Data reported as n (%) unless otherwise specified.
Data reported as median (interquartile range).